Specialty code 183500000X · San Francisco, CA
NPI
1003902792
Since 2006
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1635 Divisadero St Ste 101
San Francisco, CA, 94115
Phone (415) 833-3784
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$261K
2,487 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alaina Poon prescribed most often to Medicare patients was Atorvastatin Calcium, with 380 prescriptions and refills. In total Alaina Poon wrote 2,487 Medicare prescriptions that cost $261K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 380 | 1,265 | 140 | $4,679 |
| Metformin Hcl Er Metformin Hcl | 327 | 1,062 | 129 | $3,133 |
| Metformin Hcl Generic | 185 | 616 | 77 | $2,314 |
| Glipizide Er Glipizide | 143 | 470 | 53 | $3,179 |
| Ozempic Semaglutide | 130 | 135 | 24 | $96K |
| Humulin N Insulin Nph Human Isophane | 112 | 322 | 49 | $15K |
| Insulin Glargine-Yfgn Generic | 107 | 308 | 59 | $10K |
| Glipizide Generic | 101 | 337 | 40 | $1,153 |
| Simvastatin Generic | 81 | 270 | 29 | $959 |
| Losartan Potassium Generic | 76 | 253 | 28 | $954 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 62 | 157 | 24 | $11K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 61 | 163 | 28 | $1,547 |
| Amlodipine Besylate Generic | 58 | 192 | 22 | $658 |
| Veo Insulin Syringe Syrge-Ndl,ins 0.3 Ml Half Mark | 57 | 166 | 25 | $1,153 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 51 | 141 | 26 | $1,025 |
Brand drugs: 664 claims; generic drugs: 1,580 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alaina Poon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.